Public-registry site landscape for NCT05811247, “Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)”, a OSA study sponsored by Apnimed. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05811247 (registry record) |
| Study title | Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) |
| Official title | Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of Aroxybutynin/Atomoxetine (AD109) to Placebo in Obstructive Sleep Apnea (LunAIRo Study) |
| Sponsor | Apnimed |
| Condition(s) | OSA |
| Phase | PHASE3 |
| Listed sites | 64 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT05811247.
Eichor generates a preliminary site-risk snapshot for NCT05811247 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
